VSV-ZEBOV Geneva Vaccine Trial

Clinical trial NCT02287480 · COMPLETED

Trial details

NCT number: NCT02287480
Sponsor: University Hospital, Geneva
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ebolavirus Disease

Start date: 2014-11-01
Primary completion: 2015-04-01
Enrollment: 115

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.